Search Results

Bicalutamide: Carcinoid tumour (first report) in an elderly patient

Source: Reactions, Volume 1, Number 1281, 2009-12-05 , pp. 9-9(1)

Publisher: Adis International

Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment

Authors: Müller, Sebastian; Holzapfel, Korbinian; Seidl, Christof; Treiber, Uwe; Krause, Bernd; Senekowitsch-Schmidtke, Reingard

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 36, Number 9, September 2009 , pp. 1434-1442(9)

Publisher: Springer

Increased mortality risk with HT in prostate cancer with comorbidities

Source: Reactions, Volume 1, Number 1268, 2009-09-05 , pp. 3-3(1)

Publisher: Adis International

Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values

Authors: Wadhwa, Vivek K.; Weston, Robin; Mistry, Rahul; Parr, Nigel J.

Source: BJU International, Volume 104, Number 6, September 2009 , pp. 800-805(6)

Publisher: Blackwell Publishing

Long-term androgen suppression impact on QOL "acceptable"

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 13-13(1)

Publisher: Adis International

Suppression of mutant androgen receptors by flutamide

Authors: Ishioka, Junichiro; Hara, Shuntaro; Isaacs, John T; Tomura, Arihiro; Nishikawa, Kiyohiro; Kageyama, Yukio

Source: International Journal of Urology, Volume 16, Number 5, May 2009 , pp. 516-521(6)

Publisher: Blackwell Publishing

Synthesis of Potential Impurities of Bicalutamide

Authors: Bhise, Nandu Baban; Sathe, Dhananjay Govind; Radhakrishanan, Tarur; Deore, Raviraj

Source: Synthetic Communications, Volume 39, Number 9, January 2009 , pp. 1516-1526(11)

Publisher: Taylor and Francis Ltd

Profound bicalutamide withdrawal syndrome in a hormone-refractory T4N1 prostate cancer permitting both salvage radiotherapy and cessation of hormonal therapy

Source: International Journal of Urology, Volume 16, Number 3, March 2009 , pp. 337-338(2)

Publisher: Blackwell Publishing

Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy

Authors: Mignogna, M.D.; Fortuna, G.; Leuci, S.; Adamo, D.; Ruoppo, E.

Source: British Journal of Dermatology, Volume 160, Number 2, February 2009 , pp. 468-470(3)

Publisher: Blackwell Publishing

Bicalutamide/leuprorelin: Organising pneumonia and bronchiolitis in an elderly patient: case report

Source: Reactions, Volume 1, Number 1232, 2008-12-13 , pp. 10-10(1)

Publisher: Adis International

Bicalutamide: Liver failure: case report

Source: Reactions, Volume 1, Number 1229, 2008-11-22 , pp. 7-7(1)

Publisher: Adis International

Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines

Authors: Burich, Rebekah A.; Holland, William S.; Vinall, Ruth L.; Tepper, Clifford; deVere White, Ralph W.; Mack, Philip C.

Source: BJU International, Volume 102, Number 10, November 2008 , pp. 1458-1466(9)

Publisher: Blackwell Publishing

Androgens upregulate aquaporin 9 expression in the prostate

Authors: Wang, Jianbo; Tanji, Nozomu; Sasaki, Toyokazu; Kikugawa, Tadahiko; Song, Xishuang; Yokoyama, Masayoshi

Source: International Journal of Urology, Volume 15, Number 10, October 2008 , pp. 936-941(6)

Publisher: Blackwell Publishing

Bicalutamide receives additional exclusivity in the US.

Source: Inpharma, Volume 1, Number 1657, 2008-09-27 , pp. 22-22(1)

Publisher: Adis International

Bicalutamide: Fulminant hepatotoxicity: case report

Source: Reactions, Volume 1, Number 1214, 2008-08-09 , pp. 10-10(1)

Publisher: Adis International

Etoricoxib appears to be beneficial during off-phases of intermittent androgen deprivation therapy

Source: Inpharma, Volume 1, Number 1643, 2008-06-21 , pp. 19-19(1)

Publisher: Adis International

The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer

Authors: Iversen, Peter; Roder, Martin Andreas

Source: Expert Review of Anticancer Therapy, Volume 8, Number 3, March 2008 , pp. 361-369(9)

Publisher: Expert Reviews

Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer

Authors: Dockery, Frances; Bulpitt, Christopher J.; Agarwal, Sanjiv; Vernon, Clare; Nihoyannopoulos, Petros; Kemp, Martin; Hooper, James; Rajkumar, Chakravarthi

Source: Clinical Endocrinology, Volume 68, Number 1, January 2008 , pp. 59-65(7)

Publisher: Blackwell Publishing

Spectral Characteristics of Bicalutamide Drug in Different Solvents and β-Cyclodextrin

Authors: Smith, A.; Kannan, K.; Manavalan, R.; Rajendiran, N.

Source: Journal of Inclusion Phenomena and Macrocyclic Chemistry, Volume 58, Numbers 1-2, June 2007 , pp. 161-167(7)

Publisher: Springer

Treatment of bicalutamide-induced breast events

Author: Sieber, Paul R

Source: Expert Review of Anticancer Therapy, Volume 7, Number 12, December 2007 , pp. 1773-1779(7)

Publisher: Expert Reviews